K2 (MK-7)
La vitamina K2 (MK-7) es una vitamina liposoluble que juega un papel crucial en la salud ósea y cardiovascular. Es un subtipo de vitamina K2, conocido como menaquinona-7, que se produce por fermentación bacteriana.
Resumen de Efectividad y Riesgos
Condición | Efectividad | Detalles |
|---|---|---|
| Osteoporosis | MK-7 supplementation has been associated with improved bone mineral density and reduced risk of osteoporotic fractures, particularly in older adults and postmenopausal women, by enhancing bone mineralization. | |
| Salud Cardiovascular | By preventing arterial calcification and supporting vascular health, K2 (MK-7) contributes to overall cardiovascular health. Research indicates a reduction in cardiovascular events and mortality with adequate MK-7 intake. | |
| Salud Ósea | MK-7, a form of Vitamin K2, is crucial for bone health as it helps in the activation of osteocalcin, a protein necessary for bone mineralization. Studies have demonstrated that MK-7 supplementation can improve bone density and reduce the risk of fractures. | |
| Calcificación de las arterias/Ateroesclerosis | K2 (MK-7) has been shown to inhibit the progression of arterial calcification and reduce the risk of cardiovascular disease by activating matrix Gla protein (MGP), a potent inhibitor of arterial calcification. Clinical trials and observational studies support its beneficial effects on cardiovascular health. | |
| Calcificación Vascular | K2 (MK-7) is known to prevent vascular calcification by activating MGP. This action is critical in reducing the risk of cardiovascular diseases associated with calcification. | |
| Puede interactuar con anticoagulantes. | La vitamina K2 (MK-7) puede contrarrestar los efectos de los medicamentos anticoagulantes, como la warfarina, al promover la coagulación sanguínea, lo que puede llevar a un mayor riesgo de trombosis. |
Suplemento Recomendado